Your prediction
Adamis Pharmaceuticals Corp. Stock
Our community identified positive and negative aspects for Adamis Pharmaceuticals Corp. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Adamis Pharmaceuticals Corp. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Adamis Pharmaceuticals Corp. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Adamis Pharmaceuticals Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Adamis Pharmaceuticals Corp. | - | - | - | - | - | - | - |
| Pacira Pharmaceuticals | -1.850% | -9.402% | -4.505% | 12.766% | -1.852% | -39.429% | -58.431% |
| Corcept Therapeutics Inc. | 0.980% | -8.713% | 16.987% | 54.861% | 36.970% | 229.789% | 414.615% |
| Supernus Pharmaceuticals | -1.060% | -7.882% | -10.526% | 15.432% | -13.023% | 30.769% | 66.964% |
Comments
Adamis Pharmaceuticals Co. (NASDAQ: ADMP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ADMP provided by MarketBeat
